Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2004-04-21

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/JAMA.291.15.1887PMID 15100209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comorbidity of Alcohol, Drug, and Psychiatric Disorders: Epidemiology

  2004cited by this paper
• The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial.

  2004cited by this paper
• Comprehensive Meta-Analysis

  2004cited by this paper
• Overview of Treatment Modalities for Dual-Diagnosis Patients: Pharmacotherapy, Psychotherapy, and 12-Step Programs

  2004cited by this paper
• The use of antidepressants in alcohol-dependent veterans.

  2003cited by this paper
• Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management

  2003cited by this paper
• The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

  2003cited by this paper
• Motivational interviewing: Preparing people for change, 2nd ed.

  2003cited by this paper
• Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial

  2003cited by this paper
• Impact of alcohol detoxification on anxiety and depressive symptoms.

  2002cited by this paper
• Motivational interviewing: preparing people for change.

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Placebo response in studies of major depression: variable, substantial, and growing.

  2002cited by this paper
• A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms.

  2002cited by this paper
• A sensitivity analysis for publication bias in systematic reviews

  2001cited by this paper
• The quality of care for depressive and anxiety disorders in the United States.

  2001cited by this paper
• Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.

  2001cited by this paper
• Double-Blind Clinical Trial of Sertraline Treatment for Alcohol Dependence

  2001cited by this paper
• Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.

  2000cited by this paper
• Managing depression in medical outpatients.

  2000cited by this paper
• Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.

  2000cited by this paper
• Practical Meta-Analysis

  2000cited by this paper
• Suicide attempts in major affective disorder patients with comorbid substance use disorders.

  1999cited by this paper
• Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

  1999cited by this paper
• Fluoxetine versus placebo for the marijuana use of depressed alcoholics.

  1999cited by this paper
• Placebo-controlled study of sertraline in depressed recently abstinent alcoholics.

  1998cited by this paper
• Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.

  1998cited by this paper
• Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.

  1998cited by this paper
• Fluoxetine versus placebo in depressed alcoholic cocaine abusers.

  1998cited by this paper
• Double-blind fluoxetine in depressed alcoholic smokers.

  1997cited by this paper
• Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.

  1997cited by this paper
• Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices.

  1997cited by this paper
• Cognitive-behavioral treatment for depression in alcoholism.

  1997cited by this paper
• Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.

  1997cited by this paper
• Empirical Evidence of Bias. Dimensions of Methodological Quality Associated with Estimates of Treatment Effects in Controlled Trials

  1996cited by this paper
• A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.

  1996cited by this paper
• Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial.

  1996cited by this paper
• Imipramine treatment of cocaine abuse: possible boundaries of efficacy.

  1995cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients.

  1995cited by this paper
• Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.

  1995cited by this paper
• Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.

  1995cited by this paper
• Antidepressant treatment in methadone maintenance patients.

  1995cited by this paper
• A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders.

  1995cited by this paper
• Differential Symptom Reduction in Depressed Cocaine Abusers Treated with Psychotherapy and Pharmacotherapy

  1995cited by this paper
• Imipramine treatment of alcoholism with comorbid depression.

  1993cited by this paper
• Baclofen administration for the treatment of affective disorders in alcoholic patients.

  1993cited by this paper
• Achieving cocaine abstinence with a behavioral approach.

  1993cited by this paper
• Dual Diagnosis

  1993cited by this paper
• Adjunctive imipramine for dysphoric schizophrenic patients with past histories op cannabis abuse

  1992cited by this paper
• Multiple risk factors predict suicide in alcoholism.

  1992cited by this paper
• Incorporating variations in the quality of individual randomized trials into meta-analysis.

  1992cited by this paper
• Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse.

  1992cited by this paper
• Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

  1991cited by this paper
• Depression as a prognostic factor for pharmacological treatment of cocaine dependence.

  1991cited by this paper
• Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.

  1991cited by this paper
• Desipramine treatment of alcoholism.

  1991cited by this paper
• Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study.

  1990cited by this paper
• Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

  1990cited by this paper
• Alcoholism and depression: a placebo controlled study with viloxazine.

  1990cited by this paper
• Suicidality, depression, and substance abuse in adolescence: Levy JC, Deykin EY Am J Psychiatry 146:1462–1467 Nov 1989

  1990cited by this paper
• Suicidality, depression, and substance abuse in adolescence.

  1989cited by this paper
• Statistical Power Analysis for the Behavioral Sciences (2nd ed.)

  1989cited by this paper
• Changes in depression among abstinent alcoholics.

  1988cited by this paper
• Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review.

  1987cited by this paper
• Long-term changes in current psychiatric diagnoses of treated opiate addicts.

  1986cited by this paper
• Genetic and clinical implications of alcoholism and affective disorder.

  1986cited by this paper
• Mianserin in the treatment of depressive symptoms in alcoholics. A double-blind placebo controlled study using a computer delivered self-rating scale.

  1986cited by this paper
• Treatment of Depression in Chronic Cocaine and Phencyclidine Abuse With Desipramine

  1986cited by this paper
• Imipramine as treatment for depression in addicts.

  1983cited by this paper
• Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.

  1982cited by this paper
• THE USE OF ANTIDEPRESSANTS WITH METHADONE IN DEPRESSED MAINTENANCE PATIENTS *

  1982cited by this paper
• Tricyclic antidepressants in the treatment of depression associated with alcoholism.

  1981cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, Third Edition

  1980cited by this paper
• Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone.

  1975cited by this paper
• Treatment of depression in alcoholics.

  1975cited by this paper
• Phoenix House. Changes in psychopathological signs of resident drug addicts.

  1973cited by this paper
• Phoenix House. Changes in psychopathological signs of resident drug addicts.

  1973cited by this paper
• Antidepressant drug therapy: addicts vs. nonaddicts.

  1972cited by this paper
• Depression associated with alcohol withdrawal. Imipramine therapy compared with placebo.

  1971cited by this paper
• Tofranil in the treatment of post alcoholic depressions.

  1970cited by this paper
• REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF‐REPORT RATINGS OF HOSPITALIZED DEPRESSIVES

  1969cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Concurrent Disorders: Treatment of Comorbid Alcohol Use Disorder and Major Depressive Disorder.

  2026cites this paper
• Comorbidity Patterns in Alcohol Use Disorder: A Short-Term Residential Program Pilot Study.

  2026cites this paper
• Comparative effects of antidepressants on cocaine-induced hyperthermia in rats: a preclinical study.

  2026cites this paper
• Пароксетин в лечении пациентов с двойным диагнозом

  2025cites this paper
• Concurrent Disorders and Treatment Outcomes: A Meta-Analysis

  2025cites this paper
• Evaluation of the Effect of Severity of Separation Anxiety Disorder on Nicotine Dependence Level

  2025cites this paper
• Impact of Co-Occurring Psychiatric Comorbidities and Substance Use Disorders on Outcomes in Adolescents and Young Adults with Opioid Use Disorder: A Retrospective Cohort Study

  2025cites this paper
• Antidepressants in Alcohol Use Disorder: Balancing Evidence, Clinical Nuance, and the Risks of Deprescribing

  2025cites this paper
• Pharmacotherapy of Alcohol Dependence

  2025cites this paper
• Managing substance abuse on psychiatric units: a scoping review

  2025cites this paper
• Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder

  2025cites this paper
• Antidepressant Efficacy of Ketamine Plus Naltrexone for Major Depression Comorbid with Alcohol Use Disorder: A Randomized Controlled Trial.

  2025cites this paper
• Suicidal ideation in adults with opioid use disorder treated with buprenorphine-naloxone versus extended-release naltrexone

  2025cites this paper
• Fenofibrate treatment during withdrawal reverses symptoms of ethanol-induced depression in male rats

  2025cites this paper
• Substance-Induced Mood Disorders: A Scoping Review

  2024cites this paper
• Antidepressants and alcohol use disorder: A multicenter study on the mediating role of depression symptom changes.

  2024cites this paper
• Major Depression in Comorbidity with Substance use Disorders: Patients’ Features and Clinical-Neurobiological Rationale of Antidepressant Treatments

  2024cites this paper
• Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need

  2024cites this paper
• Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder.

  2024cites this paper
• BNST GluN2D-containing NMDARs contribute to ethanol intake but not negative affective behaviors in female mice

  2024cites this paper
• Síntomas de ansiedad, depresión y psicosis en personas en rehabilitación por drogodependencia del Valle de Aburrá

  2024cites this paper
• BNST GluN2D-containing NMDARs contribute to ethanol intake but not negative affective behaviors in female mice.

  2024cites this paper
• Drinking behavior patterns may be associated with persistent depressive symptoms after alcohol abstinence in alcohol use disorder

  2024cites this paper
• Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.

  2023cites this paper
• The Relationship between Selected Factors (Temperament, Bipolar Traits, Sleep Quality, Severity of Addiction) and Depressive Symptoms in Alcohol-Dependent Men

  2023cites this paper
• Substance Use Disorders and Medication-Assisted Therapies: Current Practices and Implications for Nursing.

  2023cites this paper
• Alcohol and the Etiology of Depression.

  2023cites this paper
• Use of Quantile Treatment Effects Analysis to Describe Antidepressant Response in Randomized Clinical Trials Submitted to the US Food and Drug Administration

  2023cites this paper
• Impact of Treating Depression on Associated Comorbidities: A Systematic Literature Review.

  2023cites this paper
• Effects of Three Serotonin Reuptake Inhibitors on Sign-Tracking in Male Sprague-Dawley Rats.

  2023cites this paper
• The causal impact of mental health on tobacco and alcohol consumption: an instrumental variables approach

  2023cites this paper
• The Dopamine System in Mediating Alcohol Effects in Humans.

  2023cites this paper
• Alcohol Withdrawal and the Associated Mood Disorders—A Review

  2022cites this paper
• The Interplay Between Addictive Behaviour and Psychopathology and Personality in Substance Use Disorder: a Network Analysis in Treatment-Seeking Patients with Alcohol and Drug Use

  2022cites this paper
• Substance use and common contributors to morbidity: A genetics perspective

  2022cites this paper
• A systematic review of virtual reality therapies for substance use disorders: Impact on secondary treatment outcomes.

  2022cites this paper
• The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression

  2022cites this paper
• Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

  2022cites this paper
• Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis

  2022cites this paper
• Specific depressive symptoms are related with different patterns of alcohol use in community-dwelling older adults.

  2022cites this paper
• Drug Use and Mental Health: Comorbidity between Substance Use and Psychiatric Disorders

  2022cites this paper
• Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use

  2022cites this paper
• A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

  2022cites this paper
• Interventions for Co-occurring Cannabis Use and Depression

  2022cites this paper
• Health insurance expansion and family violence prevention: A conceptual framework.

  2022cites this paper
• Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs

  2021cites this paper
• The Profound Heterogeneity of Substance Use Disorders: Implications for Treatment Development

  2021cites this paper
• Suicide Risk and Addiction: The Impact of Alcohol and Opioid Use Disorders

  2021cites this paper
• Exploring the impact of a transdiagnostic cognitive behavioural therapy-based intervention on a group of Malaysian adolescents with problematic drug use and emotional problems

  2021cites this paper
• [Dual diagnosis: depression and alcohol use disorder].

  2021cites this paper
• Addictions and Substance Misuse

  2021cites this paper
• Clinical interventions for adults with comorbid alcohol use and depressive disorders: A systematic review and network meta-analysis

  2021influential citation
• Is behavioral activation an effective and acceptable treatment for co-occurring depression and substance use disorders? A meta-analysis of randomized controlled trials.

  2021cites this paper
• Novel Opipramol-Baclofen Combination Alleviates Depression and Craving and Facilitates Recovery From Substance Use Disorder—An Animal Model and a Human Study

  2021cites this paper
• Depressive symptoms in early alcohol or opioid abstinence: course & correlates

  2021cites this paper
• Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review.

  2021cites this paper
• Study of relationship between Effective Factors in Addiction Tendency with Psychological Dimensions of Addicts who referred to Health Settings in Urmia

  2021cites this paper
• Teaching Residents to Treat Substance Use Disorders: Overcoming 10 Common Patient-Perceived Barriers to Outpatient Treatment Engagement

  2021cites this paper
• "Take Care of You" - Efficacy of integrated, minimal-guidance, internet-based self-help for reducing co-occurring alcohol misuse and depression symptoms in adults: Results of a three-arm randomized controlled trial.

  2021cites this paper
• Association of selective serotonin reuptake inhibitor (SSRI) treatment with acute substance misuse outcomes.

  2021cites this paper
• Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis.

  2020cites this paper
• Examination of using alcohol to cope, depressive symptoms, and perceived social support in persons with HIV and Hepatitis C

  2020cites this paper
• Psychiatric Comorbidity in Major Depressive Disorder

  2020cites this paper
• Working memory training improves emotion regulation in drug abstainers: Evidence from frontal alpha asymmetry.

  2020cites this paper
• Cocaine Addiction and Treatment

  2020cites this paper
• Chronic Pain in Relation to Depressive Disorders and Alcohol Abuse

  2020cites this paper
• Bidirectional relationship between heroin addiction and depression: Behavioural and neural studies

  2020influential citation
• Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.

  2020cites this paper
• Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.

  2020cites this paper
• Impact of Substance Use Disorder on Quality of Inpatient Mental Health Services for People With Anxiety and Depression

  2020cites this paper
• Alcohol Induced Depression: Clinical, Biological and Genetic Features

  2020cites this paper
• Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis: Traitement Pharmacologique des Troubles de L’humeur et des Dépendances Comorbides: Une Revue Systématique et une Méta-Analyse

  2020cites this paper
• Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments

  2020cites this paper
• Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients.

  2020cites this paper
• Co-occurring Mood and Substance Use Disorders

  2020cites this paper
• A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder

  2020cites this paper
• Impact of Personality Disorder on the Treatment of Psychiatric Disorders in People Receiving Methadone-Assisted Treatment.

  2019cites this paper
• Prevention, screening, and treatment for heavy drinking and alcohol use disorder.

  2019cites this paper
• Prevention of suicide and reduction of self-harm among people with substance use disorder: A systematic review and meta-analysis of randomised controlled trials.

  2019cites this paper
• Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment

  2019cites this paper
• Alcohol Use Disorder and Depressive Disorders

  2019cites this paper
• revention of suicide and reduction of self-harm among people with ubstance use disorder: A systematic review and meta-analysis of andomised controlled trials

  2019cites this paper
• Study protocol for a systematic review of evidence for digital interventions for comorbid excessive drinking and depression in community-dwelling populations

  2019cites this paper
• Pharmacotherapeutic options for co-morbid depression and alcohol dependence

  2019cites this paper
• Rethinking the Use of Antidepressants to Treat Alcohol Use Disorders and Depression Comorbidity: The Role of Neurogenesis

  2019cites this paper
• Suicide among people treated for drug use disorders: a Danish national record-linkage study

  2019cites this paper
• Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

  2019cites this paper
• Alkoholkonsumstörungen und Suizidalität: Ein narratives Review

  2019cites this paper
• Prevalence of problem drinking in patients with depression and association between depression severity and problem drinking: a cross-sectional survey

  2019cites this paper
• Network Analysis and Precision Rehabilitation for the Post-concussion Syndrome

  2019cites this paper
• Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders.

  2019cites this paper
• Prevalence and Predictors of Symptoms of Depression Among Individuals Seeking Treatment from Australian Drug and Alcohol Outpatient Clinics

  2019cites this paper
• Treatment for Substance Use Disorder With Co-Occurring Mental Illness.

  2019cites this paper
• Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder.

  2019cites this paper
• Animal models of major depressive disorder and the implications for drug discovery and development

  2019cites this paper
• Bupropion, a possible antidepressant without negative effects on alcohol relapse.

  2019cites this paper
• press). Prevention of suicide and reduction of self-harm among people with substance use disorder: A systematic review and meta-analysis of randomised controlled trials. Comprehensive Psychiatry, 96,

  2019cites this paper
• Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability

  2019cites this paper
• Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

  2019cites this paper
• Treatment‐resistant depression as risk factor for substance use disorders—a nation‐wide register‐based cohort study

  2019cites this paper